Board of Directors
Professor Fang-Xu Jiang
Founder and Executive Director
Professor Fang-Xu Jiang is a MD, world recognized stem cell biologist with extensive experience, expertise and skills in translational diabetes medicine in both Australia and China. He obtained PhD from the University of Melbourne and held various leadership roles during his academic career. He was an Associate Professor at the University of Western Australia and the founding head of, the Islet Cell Development Program in the Harry Perkins Institute of Medical Research, mentor of PhD and postdoctoral students. He is Adjunct Professor of the University of Western Australia and guest/visiting/honorary Professor of four prestigious Chinese universities.
Dr Helen Jiang
Director
Dr Helen Jiang is Director and designated science and technology successor. She held Bachelor of Commerce and MD of the University of Western Australia. She also is Registrar of Northern Health, Melbourne, Australia.
Management Team
Professor Fang-Xu Jiang
Founder and Executive Director
Chief Scientific Officer. Dr Fang-Xu Jiang is Adjunct Professor of the University of Western Australia and guest/visiting/honorary Professor of four prestigious Chinese universities.
Dr Helen Jiang
Chief of Clinical Science
Chief of Clinical Science and designated successor of science and technology. Dr Helen Jiang was awarded a Bachelor of Commerce and MD of the University of Western Australia. She is Registrar, Melbourne Northern Health.
Jasper Chen
Senior Financial Representative
Senior financial representative. Mr Jasper Chen was awarded a MBA from Sydney University of Technology, executive director of Wellton International Pty Ltd (Australia), co-founder and current director of Xiamen Haitang Asset Management Co., Ltd. in China.
Emily Jiang
Chief of Legal Affairs
Chief of Legal Affair. Emily Jiang was awarded double degree of finance and law from Monash University and admitted to practice in England & Wales and Victoria, Australia. She is an associate in the Project Development and Finance practice group based in White & Case LLP’s Tokyo office.
Advisory Board
Professor Wei Wang
Chair, Board of Scientific Advisory. Professor Wei Wang is Pro-Vice-Chancellor (China) of Edith Cowan University (ECU), and a member of the expert panel advising the WHO on ‘Grand Challenges in Genomics for Public Health in Developing Countries’. He is also a steering committee member of the OECD initiative on Public Health Genomics. In 2017 Professor Wang was elected as a Fellow of the Royal Society of Medicine of United Kingdom. He has published over 200 scientific papers in prestigious journals including Science, Nature Genetics and The Lancet.
Professor Wei Wang
Member, Board of Clinical Advisory. Professor Wei Wang, Chief Physician, Professor, Head of Endocrinology Department, Xiang`an Hospital of Xiamen University, Mentors for Master and Postdoctoral Research students. Research Interests: Protective mechanism of islet beta cell function, Metabolic spectrum characteristics of diabetes mellitus and Mechanism of chronic wound and diabetic foot. Expertise: Endocrine Diseases, Diabetes, Hyperthyroidism, Diabetic foot.
